Aug 15 |
FDA clears Gilead drug acquired in $4.3B buyout
|
Aug 14 |
Insider Sale: Johanna Mercier Sells 5,490 Shares of Gilead Sciences Inc (GILD)
|
Aug 14 |
Gilead wins FDA nod for liver disease drug
|
Aug 14 |
Gilead’s Livdelzi (Seladelpar) Granted Accelerated Approval for Primary Biliary Cholangitis by U.S. FDA
|
Aug 14 |
7 Defensive Stocks to Buy as Investors Seek Shelter
|
Aug 13 |
Gilead Sciences Second Quarter 2024 Earnings: Beats Expectations
|
Aug 13 |
Gilead and the Elton John AIDS Foundation Announce Additional Five Years of RADIAN Partnership To Help Address the Growing HIV Crisis in Eastern Europe and Central Asia
|
Aug 10 |
Gilead exits J&J royalty deal for liver drug ahead of potential FDA nod
|
Aug 10 |
3 Stocks Retirees Should Absolutely Love
|
Aug 9 |
Q2 2024 Gilead Sciences Inc Earnings Call
|